Sun Pharmaceutical Industries Ltd. closed 13.94% below its 52-week high of 1,960.20 rupees, which the company achieved on September 30th.

Nagaraj Shetti of HDFC Securities recommends these two stocks to buy in the short-term - Bajaj Finserv Ltd, and Sun ...

The NIFTY MIDCAP 150 index reflects the performance of mid-sized companies, providing investors with insights into this ...

Welcome to the Sun Pharma Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most ...

Pharmazz, Inc. ("Pharmazz" or the "Company"), a late-stage biopharmaceutical company developing innovative therapies for unmet medical needs in critical care and neurology, has announced a $25 million ...

Stay informed with the Sun Pharma Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of ...

The leading 30 pharmaceutical companies, with revenues above Rs 2,500 crore, have registered robust net profit growth of 31 per cent during the financial year 2024-25 on account of new product ...

Explore how India's 20-year product patent regime transformed its pharma industry from generics to innovation, the economic ...

President Donald Trump’s pick to be U.S. surgeon general has said the nation’s medical and food systems are corrupted by ...

Wolfspeed bankruptcy watch, North Carolina lands more data centers, Duke University’s funding crunch, and an AI companion ...

Top gainers and losers in the Indian stock market after RBI's surprise rate cut announcement, impacting various sectors ...

Sun Pharmaceutical Industries Ltd. closed 14.30% below its 52-week high of 1,960.20 rupees, which the company reached on ...